334 related articles for article (PubMed ID: 22174648)
1. Oncolytic activities of host defense peptides.
Al-Benna S; Shai Y; Jacobsen F; Steinstraesser L
Int J Mol Sci; 2011; 12(11):8027-51. PubMed ID: 22174648
[TBL] [Abstract][Full Text] [Related]
2. Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment.
Mader JS; Hoskin DW
Expert Opin Investig Drugs; 2006 Aug; 15(8):933-46. PubMed ID: 16859395
[TBL] [Abstract][Full Text] [Related]
3. Genotoxic and cytotoxic activity of host defense peptides against human soft tissue sarcoma in an in vitro model.
Steinstraesser L; Hauk J; Al-Benna S; Langer S; Ring A; Kesting M; Sudhoff H; Becerikli M; Käfferlein H; Jacobsen F
Drug Chem Toxicol; 2012 Jan; 35(1):96-103. PubMed ID: 21851146
[TBL] [Abstract][Full Text] [Related]
4. Outer Membrane Vesicles Protect Gram-Negative Bacteria against Host Defense Peptides.
Balhuizen MD; van Dijk A; Jansen JWA; van de Lest CHA; Veldhuizen EJA; Haagsman HP
mSphere; 2021 Aug; 6(4):e0052321. PubMed ID: 34232080
[TBL] [Abstract][Full Text] [Related]
5. Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts.
Hilchie AL; Doucette CD; Pinto DM; Patrzykat A; Douglas S; Hoskin DW
Breast Cancer Res; 2011 Oct; 13(5):R102. PubMed ID: 22023734
[TBL] [Abstract][Full Text] [Related]
6. [Host defense peptides and peptidomimetics as new weapons for cancer treatment].
Lapis K
Magy Onkol; 2010 Mar; 54(1):47-58. PubMed ID: 20350868
[TBL] [Abstract][Full Text] [Related]
7. Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane.
Dai Y; Cai X; Shi W; Bi X; Su X; Pan M; Li H; Lin H; Huang W; Qian H
Amino Acids; 2017 Sep; 49(9):1601-1610. PubMed ID: 28664269
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of novel peptides based on antimicrobial peptides as potential agents with antitumor and multidrug resistance-reversing activities.
Zhang B; Shi W; Li J; Liao C; Yang L; Huang W; Qian H
Chem Biol Drug Des; 2017 Nov; 90(5):972-980. PubMed ID: 28524273
[TBL] [Abstract][Full Text] [Related]
9. Cryptic Host Defense Peptides: Multifaceted Activity and Prospects for Medicinal Chemistry.
de Oliveira Costa B; Franco OL
Curr Top Med Chem; 2020; 20(14):1274-1290. PubMed ID: 32209042
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer, immunoregulatory, and antimicrobial activities of the frog skin host-defense peptides pseudhymenochirin-1Pb and pseudhymenochirin-2Pa.
Mechkarska M; Attoub S; Sulaiman S; Pantic J; Lukic ML; Conlon JM
Regul Pept; 2014 Nov; 194-195():69-76. PubMed ID: 25447194
[TBL] [Abstract][Full Text] [Related]
11. Novel cationic antimicrobial peptide GW-H1 induced caspase-dependent apoptosis of hepatocellular carcinoma cell lines.
Chen YL; Li JH; Yu CY; Lin CJ; Chiu PH; Chen PW; Lin CC; Chen WJ
Peptides; 2012 Aug; 36(2):257-65. PubMed ID: 22659412
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications.
Deslouches B; Di YP
Oncotarget; 2017 Jul; 8(28):46635-46651. PubMed ID: 28422728
[TBL] [Abstract][Full Text] [Related]
13. Host Defense Peptides and Cancer; Perspectives on Research Design and Outcomes.
Otvos L
Protein Pept Lett; 2017; 24(10):879-886. PubMed ID: 28155618
[TBL] [Abstract][Full Text] [Related]
14. SSTP1, a Host Defense Peptide, Exploits the Immunomodulatory IL6 Pathway to Induce Apoptosis in Cancer Cells.
Gopalakrishnan S; Uma SK; Mohan G; Mohan A; Shanmugam G; Kumar VTV; J S; Chandrika SK; Vasudevan D; Nori SRC; Sathi SN; George S; Maliekal TT
Front Immunol; 2021; 12():740620. PubMed ID: 34867962
[TBL] [Abstract][Full Text] [Related]
15. Utilizing Organoid and Air-Liquid Interface Models as a Screening Method in the Development of New Host Defense Peptides.
Choi KG; Wu BC; Lee AH; Baquir B; Hancock REW
Front Cell Infect Microbiol; 2020; 10():228. PubMed ID: 32509598
[TBL] [Abstract][Full Text] [Related]
16. Suppression of soft tissue sarcoma growth by a host defense-like lytic peptide.
Steinstraesser L; Hauk J; Schubert C; Al-Benna S; Stricker I; Hatt H; Shai Y; Steinau HU; Jacobsen F
PLoS One; 2011 Mar; 6(3):e18321. PubMed ID: 21483840
[TBL] [Abstract][Full Text] [Related]
17. Emerging themes and therapeutic prospects for anti-infective peptides.
Yount NY; Yeaman MR
Annu Rev Pharmacol Toxicol; 2012; 52():337-60. PubMed ID: 22235859
[TBL] [Abstract][Full Text] [Related]
18. Host Defense Peptides: Dual Antimicrobial and Immunomodulatory Action.
Drayton M; Deisinger JP; Ludwig KC; Raheem N; Müller A; Schneider T; Straus SK
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681833
[TBL] [Abstract][Full Text] [Related]
19. Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat.
Tripathi AK; Kumari T; Tandon A; Sayeed M; Afshan T; Kathuria M; Shukla PK; Mitra K; Ghosh JK
Acta Biomater; 2017 Jul; 57():170-186. PubMed ID: 28483698
[TBL] [Abstract][Full Text] [Related]
20. The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells.
Eike LM; Yang N; Rekdal Ø; Sveinbjørnsson B
Oncotarget; 2015 Oct; 6(33):34910-23. PubMed ID: 26472184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
